2588110-62-5
Chemical Structure
CDK7-IN-10
- CAS No.: 2588110-62-5
- Formula:C29H35N7O3
- Molecular Weight:529.63
IUPAC Name: (S)-3-(4-acrylamidobenzamido)-N-(2-(dimethylamino)-1-phenylethyl)-1,6,6-trimethyl-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide
InChIKey: LTMXBUKGMDPOPI-HSZRJFAPSA-N
SMILES: O=C(C1=CC=C(C=C1)NC(C=C)=O)NC2=NN(C)C3=C2CN(C(N[C@@H](C4=CC=CC=C4)CN(C)C)=O)C3(C)C
Biological Activity: CDK7-IN-10 is a CDK7 inhibitor with an IC50 of less than 100 nM, extracted from patent WO2021016388A1, compound I-1. CDK7-IN-10 is useful in inhibiting the activity of a kinase. CDK7-IN-10 has the potential of inhibiting cell growth and inducing cell apoptosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK7-IN-10 | CDK7-IN-10 is a CDK7 inhibitor with an IC50 of less than 100 nM, extracted from patent WO2021016388A1, compound I-1. CDK7-IN-10 is useful in inhibiting the activity of a kinase. CDK7-IN-10 has the potential of inhibiting cell growth and inducing cell apoptosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
